These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

238 related items for PubMed ID: 36217728

  • 1. Fibrinolytic Changes in Women with Preeclampsia.
    Godtfredsen AC, Sidelmann JJ, Dolleris BB, Jørgensen JS, Johansen EKJ, Pedersen MFB, Palarasah Y, Gram JB.
    Clin Appl Thromb Hemost; 2022; 28():10760296221126172. PubMed ID: 36217728
    [Abstract] [Full Text] [Related]

  • 2. [Relationship between plasma levels of thrombin activatable fibrinolysis inhibitor, plasminogen activator inhibitor-1 and tissue-type plasminogen activator and deep venous thrombosis in patients with systemic lupus erythematosus].
    Liu YF, Hou N, Shi YJ, Li CX, Gao YJ, Liu LN.
    Zhonghua Yi Xue Za Zhi; 2023 Jun 06; 103(21):1638-1642. PubMed ID: 37248064
    [Abstract] [Full Text] [Related]

  • 3. Fibrinolysis parameters in Sudanese women with severe preeclampsia.
    Elzein HO, Muddathir AR, Rida M, Rayis DA, Elhassan EM, Adam I.
    Hypertens Pregnancy; 2016 Nov 06; 35(4):559-564. PubMed ID: 27598010
    [Abstract] [Full Text] [Related]

  • 4. Fibrin lysability is associated with central obesity and inflammation in women with polycystic ovary syndrome.
    Godtfredsen ACM, Sidelmann JJ, Gram JB, Andersen M, Glintborg D.
    Acta Obstet Gynecol Scand; 2020 Aug 06; 99(8):1078-1084. PubMed ID: 32048272
    [Abstract] [Full Text] [Related]

  • 5. The suboptimal fibrinolytic response in COVID-19 is dictated by high PAI-1.
    Whyte CS, Simpson M, Morrow GB, Wallace CA, Mentzer AJ, Knight JC, Shapiro S, Curry N, Bagot CN, Watson H, Cooper JG, Mutch NJ.
    J Thromb Haemost; 2022 Oct 06; 20(10):2394-2406. PubMed ID: 35780481
    [Abstract] [Full Text] [Related]

  • 6. Venous thrombosis risk associated with plasma hypofibrinolysis is explained by elevated plasma levels of TAFI and PAI-1.
    Meltzer ME, Lisman T, de Groot PG, Meijers JC, le Cessie S, Doggen CJ, Rosendaal FR.
    Blood; 2010 Jul 08; 116(1):113-21. PubMed ID: 20385790
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Variations in fibrinolytic parameters and inhibin-A in pregnancy: related hypertensive disorders.
    Sartori MT, Serena A, Saggiorato G, Campei S, Faggian D, Pagnan A, Paternoster DM.
    J Thromb Haemost; 2008 Feb 08; 6(2):352-8. PubMed ID: 18021302
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Variable Resistance to Plasminogen Activator Initiated Fibrinolysis for Intermediate-Risk Pulmonary Embolism.
    Stubblefield WB, Alves NJ, Rondina MT, Kline JA.
    PLoS One; 2016 Feb 08; 11(2):e0148747. PubMed ID: 26866684
    [Abstract] [Full Text] [Related]

  • 11. Physical activity status and adverse age-related differences in coagulation and fibrinolytic factors in women.
    DeSouza CA, Jones PP, Seals DR.
    Arterioscler Thromb Vasc Biol; 1998 Mar 08; 18(3):362-8. PubMed ID: 9514404
    [Abstract] [Full Text] [Related]

  • 12. Recognition of Plasminogen Activator Inhibitor Type 1 as the Primary Regulator of Fibrinolysis.
    Urano T, Suzuki Y, Iwaki T, Sano H, Honkura N, Castellino FJ.
    Curr Drug Targets; 2019 Mar 08; 20(16):1695-1701. PubMed ID: 31309890
    [Abstract] [Full Text] [Related]

  • 13. The hyperfibrinolytic state of mice with combined thrombin-activatable fibrinolysis inhibitor (TAFI) and plasminogen activator inhibitor-1 gene deficiency is critically dependent on TAFI deficiency.
    Vercauteren E, Peeters M, Hoylaerts MF, Lijnen HR, Meijers JC, Declerck PJ, Gils A.
    J Thromb Haemost; 2012 Dec 08; 10(12):2555-62. PubMed ID: 23083123
    [Abstract] [Full Text] [Related]

  • 14. Prolonged duration of type 2 diabetes is associated with increased thrombin generation, prothrombotic fibrin clot phenotype and impaired fibrinolysis.
    Konieczynska M, Fil K, Bazanek M, Undas A.
    Thromb Haemost; 2014 Apr 01; 111(4):685-93. PubMed ID: 24306139
    [Abstract] [Full Text] [Related]

  • 15. Fibrinolysis during normal human pregnancy: complex inter-relationships between plasma levels of tissue plasminogen activator and inhibitors and the euglobulin clot lysis time.
    Wright JG, Cooper P, Astedt B, Lecander I, Wilde JT, Preston FE, Greaves M.
    Br J Haematol; 1988 Jun 01; 69(2):253-8. PubMed ID: 3134043
    [Abstract] [Full Text] [Related]

  • 16. Increased plasminogen activator inhibitor-1, decreased tissue factor pathway inhibitor, and unchanged thrombin-activatable fibrinolysis inhibitor levels in patients with primary hyperparathyroidism.
    Erem C, Kocak M, Nuhoglu I, Yilmaz M, Ucuncu O.
    Eur J Endocrinol; 2009 May 01; 160(5):863-8. PubMed ID: 19233920
    [Abstract] [Full Text] [Related]

  • 17. Assessment of plasminogen activator inhibitor-1(PAI1) and thrombin activitable fibrinolysis inhibitor (TAFI) in Egyptian children with hemophilia A.
    Soliman M, Osman N, Hefnawy S, El Hawy MA.
    Pediatr Hematol Oncol; 2022 May 01; 39(4):318-328. PubMed ID: 34668834
    [Abstract] [Full Text] [Related]

  • 18. Plasminogen activators (t-PA and u-PA) and plasminogen activators inhibitors (PAI-1 and PAI-2) in some myeloproliferative syndromes.
    Rość D, Kremplewska-Nalezyta E, Gadomska G, Zastawna E, Michalski A, Drewniak W.
    Med Sci Monit; 2000 May 01; 6(4):684-91. PubMed ID: 11208392
    [Abstract] [Full Text] [Related]

  • 19. Haemostatic factors in women with history of preeclampsia.
    Portelinha A, Cerdeira AS, Belo L, Braga J, Tejera E, Pinto A, Pinto F, Areias MJ, Patrício B, Rebelo I.
    Thromb Res; 2009 May 01; 124(1):52-6. PubMed ID: 19049844
    [Abstract] [Full Text] [Related]

  • 20. An inhibitor of activated thrombin-activatable fibrinolysis inhibitor potentiates tissue-type plasminogen activator-induced thrombolysis in a rabbit jugular vein thrombolysis model.
    Nagashima M, Werner M, Wang M, Zhao L, Light DR, Pagila R, Morser J, Verhallen P.
    Thromb Res; 2000 May 15; 98(4):333-42. PubMed ID: 10822080
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.